Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05113797 · ClinicalTrials.gov registry record · NA
Use of the OPTIMAL Theory of Motor Learning With the Lower Quarter Y-Balance Test
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT05113797: Completed NA study, sponsored by Mayo Clinic.
NCT05113797 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 57 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05113797, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
Assessing and improving movement quality are important components of rehabilitation. The Lower Quarter Y-Balance Test (YBT-LQ) is a balance test used to assess dynamic balance in healthy adults, athletes, and those who are rehabilitating a lower extremity injury. Performing the YBT-LQ requires utilization of different strategies. It is unknown how different practice conditions will affect dynamic balance learning or performance on YBT-LQ. This study aims to compare the influence of OPTIMAL motor learning practice with standard practice conditions on YBT-LQ measurements.
Primary Outcome
Measure by 3 reach trials in 3 directions on each leg recorded to the nearest 0.5 cm. Composite score calculated by the sum of three directions for one leg divided by three times limb length, multiplied by 100
Interventions
- DIAGNOSTIC_TEST Lower Quarter Y-Balance Test
- BEHAVIORAL OPTIMAL motor learning theory
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2021-11-13 |
| Est. Completion | 2022-03-01 |
| Phase | NA |
What the finished NCT05113797 record still lists
NCT05113797 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Lower Quarter Y-Balance Test is the first listed.
NCT05113797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05113797 about?
NCT05113797 is a clinical study titled "Use of the OPTIMAL Theory of Motor Learning With the Lower Quarter Y-Balance Test". Assessing and improving movement quality are important components of rehabilitation. The Lower Quarter Y-Balance Test (YBT-LQ) is a balance test used to assess dynamic balance in healthy adults, athletes, and those who are rehabilitating a lower extremity injury. Performing the YBT-LQ requires utili...
What is the current status of trial NCT05113797?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2021-11-13. Estimated completion is 2022-03-01.
What interventions are being tested in trial NCT05113797?
The interventions under investigation include: Lower Quarter Y-Balance Test (DIAGNOSTIC_TEST), OPTIMAL motor learning theory (BEHAVIORAL).
Who is sponsoring clinical trial NCT05113797?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05113797's enrollment target sits among peer trials
57 1261st of 2000 higher than 739 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI